Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. INTC
9. CME
10. GOOGL

Go back to Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates 

Trevi Therapeutics (TRVI) Tops Q4 EPS by 4c

March 17, 2026 4:15 PM EDT

Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.

... More